GlassScriptPhysician profile
Taylor Vaughan
NPI 1467770131
$12,320.87
in general payments reported to CMS, 2019-2025
54 companies · $1,945 in 2025
The $1,945 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,311 · 2020: $254 · 2021: $1,396 · 2022: $2,766 · 2023: $2,555 · 2024: $2,095 · 2025: $1,945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,505 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,504.87 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,388.70 | 2019-2025 | Ams 700, Advance Xp, Axonics |
| Astellas Pharma US INC | $1,192.53 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Axonics, INC. | $1,085.45 | 2021-2024 | Axonics |
| Janssen Biotech, INC. | $916.68 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Coloplast Corp | $839.78 | 2021-2025 | Restorelle, Altis, Speedicath |
| Medtronic, INC. | $794.50 | 2021-2025 | Interstim, Ligasure |
| Teleflex LLC | $641.51 | 2021-2025 | Urolift |
| Sumitomo Pharma America, INC. | $526.22 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $453.11 | 2019-2025 | |
| Procept Biorobotics Corporation | $365.66 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Merck Sharp & Dohme LLC | $355.60 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $345.77 | 2021-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $296.11 | 2021-2024 | |
| Rochester Medical Corporation | $209.92 | 2019-2022 | |
| Antares Pharma, INC. | $202.05 | 2019-2025 | Xyosted, Nocdurna, Tlando |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Vaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.